Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Romark Laboratories L.C. clinical trials
The registry lists 29 studies whose lead sponsor is Romark Laboratories L.C.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 17, 2024.
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Romark Laboratories L.C..
- Romark Laboratories L.C.29 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 29 of 29.
- Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus InfectionTerminatedNCT04489381Phase 3
- Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe IllnessWithdrawnNCT05157269Phase 3
- Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe IllnessWithdrawnNCT05157243Phase 3
- Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)TerminatedNCT04343248Phase 3
- Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 InfectionCompletedNCT04359680Phase 3
- Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19CompletedNCT04486313Phase 3
- Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis BCompletedNCT03905655Phase 2
- Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated InfluenzaCompletedNCT01227421Phase 2/3
- A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated InfluenzaCompletedNCT03336619Phase 3
- Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus InfectionCompletedNCT03605862Phase 3
- Study of Nitazoxanide in Adults With Acute Uncomplicated InfluenzaTerminatedNCT01056380Phase 2
- Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated InfluenzaCompletedNCT02612922Phase 3
- Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated InfluenzaCompletedNCT01610245Phase 3
- Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated DiseaseTerminatedNCT00384527Phase 3
- Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis CCompletedNCT00495391Phase 2
- Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C PatientsCompletedNCT00637923Phase 2
- Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in ChildrenCompletedNCT00302640Phase 2/3
- Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's DiseaseTerminatedNCT00130390Phase 2
- Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in ChildrenCompletedNCT01328925Phase 2
- Nitazoxanide for the Treatment of Prolonged Diarrhea in ChildrenCompletedNCT01326338Phase 3
- 4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis CCompletedNCT00763568Phase 2
- Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis CCompletedNCT00421434Phase 2/3
- A Study to Evaluate the Use of Nitazoxanide to Treat CryptosporidiosisStatus unknownNCT00002158Not applicable
- Study of Nitazoxanide in the Treatment of Chronic Hepatitis CCompletedNCT00418639Phase 2
- Study of Nitazoxanide in the Treatment of Clostridium Difficile ColitisCompletedNCT00417872Phase 2
- Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis CCompletedNCT00418054Phase 2
- Study of Nitazoxanide in the Treatment of Amebiasis in ChildrenCompletedNCT00366730Phase 3
- Study of Nitazoxanide in the Treatment of Amebiasis in Adults and AdolescentsCompletedNCT00366236Phase 3
- Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS PatientsTerminatedNCT00004986Phase 3